Ho-Chang Lee

Dr. Ho-Chang Lee

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HLHo-Chang Lee
Ho-Chang Lee
SCSoo Youn Cho
Soo Youn Cho
HLHyun Joo Lee
Hyun Joo Lee
CKChong Jai Kim
Chong Jai Kim
JPJoong Shin Park
Joong Shin Park
JCJe G. Chi
Je G. Chi
Lee HC, et al. J Korean Med Sci. 2003 Oct;18(5):764-767. http://dx.doi.org/10.3346/jkms.2003.18.5.764

15 September 2023 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
Yosep ChongYosep Chong
Yosep Chong
SHSoon Auck Hong
Soon Auck Hong
HOHoon-Kyu Oh
Hoon-Kyu Oh
SJSoo Jin Jung
Soo Jin Jung
BKBo-Sung Kim
Bo-Sung Kim
TCThe Committee of Quality Improvement of Korean Society for Cytopathology
The Committee of Quality Improvement of Korean Society for Cytopathology
Background: The Korean Society for Cytopathology introduced a digital proficiency test (PT) in 2021. However, many doubtful opinions remain on whether digitally scanned images can satisfactorily present subtle differences in the nuclear features and chromatin patterns of cytological samples.Methods: We prepared 30 whole-slide images (WSIs) from the conventional PT archive by a selection process for digital PT. Digital and conventional PT were performed in parallel for volunteer institutes, and the results were compared using feedback. To assess the quality of cytological assessment WSIs, 12 slides were collected and scanned using five different scanners, with four cytopathologists evaluating image quality through a questionnaire.Results: Among the 215 institutes, 108 and 107 participated in glass and digital PT, respectively. No significant difference was noted in category C (major discordance), although the number of discordant cases was slightly higher in the digital PT group. Leica, 3DHistech Pannoramic 250 Flash, and Hamamatsu NanoZoomer 360 systems showed comparable results in terms of image quality, feature presentation, and error rates for most cytological samples. Overall satisfaction was observed with the general convenience and image quality of digital PT.Conclusions: As three-dimensional clusters are common and nuclear/chromatin features are critical for cytological interpretation, careful selection of scanners and optimal conditions are mandatory for the successful establishment of digital quality assurance programs in cytology.

9 September 2019 in Journal of International Medical Research
Verified
Journal Article
Open access
PDF file
SSSeung-Myoung Son
Seung-Myoung Son
CWChang Gok Woo
Chang Gok Woo
OLOk-Jun Lee
Ok-Jun Lee
SLSang-Jeon Lee
Sang-Jeon Lee
TLTaek-Gu Lee
Taek-Gu Lee
HLHo-Chang Lee
Ho-Chang Lee
Objective: The aim of this study was to identify clinicopathological factors that affect the number of lymph nodes (LNs) (12 or more) retrieved from patients with colorectal cancer (CRC), particularly those with pathologic T1 (pT1) disease. Methods: From 429 CRC patients, 75 pT1 cancers were identified and digitally scanned. Binary logistic regression analysis was performed to identify the clinicopathological factors affecting the number of LNs retrieved from all 429 patients and from the subset of patients with pT1 CRC. Results: For the 429 patients, the mean number of harvested LNs per specimen was 20 (median, 19). The number of retrieved LNs was independently associated with maximum tumor diameter > 2.3 cm and right-sided tumor location. The mean number of LNs retrieved from the 75 patients with pT1 CRC was 14 (median, 15); retrieval of 12 or more LNs from this group was independently associated with maximum tumor diameter > 14.1 mm. Conclusion: The number of LNs retrieved from patients with CRC was associated with maximum tumor diameter and right-sided tumor location. For patients with pT1 CRC, maximum tumor diameter was independently associated with the harvesting of 12 or more LNs.

13 April 2023 in Oncology Letters
Verified
Journal Article
Open access
PDF file
SSSeung-Myoung Son
Seung-Myoung Son
CWChang Gok Woo
Chang Gok Woo
OLOk-Jun Lee
Ok-Jun Lee
YKYong June Kim
Yong June Kim
HLHo-Chang Lee
Ho-Chang Lee
Inflammatory myofibroblastic tumors (IMTs), which are rare tumors, exhibit myofibroblastic differentiation, often with anaplastic lymphoma kinase (ALK) gene rearrangements. A subset of IMTs identified in the urinary tract have been shown to harbor a fibronectin 1 (FN1)‑ALK gene fusion. In this case report, a case of an IMT with FN1‑ALK fusion in the urinary bladder was presented, and its clinicopathological characteristics were reviewed. A 45‑year‑old female was referred to Chungbuk National University Hospital with gross hematuria. Cystoscopy revealed a solid mass in the bladder. The patient subsequently underwent transurethral resection of the lesion. The mass comprised stellate and spindled myofibroblastic cells that were arranged in loose fascicles, with a myxoid background and a mixed inflammatory infiltrate. Immunohistochemical analysis revealed that the tumor cells were positive for vimentin, cytokeratin AE1/AE3 and ALK, and focal‑positive for desmin. Targeted next‑generation sequencing was subsequently employed to identify the FN1‑ALK fusion. To date, the patient has undergone outpatient follow‑up for 18 months, with no signs of tumor recurrence. To conclude, in total, FN1 has been identified as an ALK fusion partner almost exclusively in cases of genitourinary IMTs [13 bladder IMTs (including the present case) and two uterine IMTs]. In the present case, the FN1‑ALK fusion was found to involve ALK exon 19 and FN1 exon 23. By contrast, the majority of the other IMTs with an ALK fusion have involved ALK exon 20, whereas ALK fusion involving ALK exon 18 or 19 has been reported only in genitourinary IMTs. Therefore, the FN1‑ALK fusion involving ALK exon 18 or 19 may be specific to a subset of IMTs arising in the urinary bladder.

15 November 2021 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
HKHye Ju Kang
Hye Ju Kang
SKSun Young Kwon
Sun Young Kwon
AKAhrong Kim
Ahrong Kim
WKWoo Gyeong Kim
Woo Gyeong Kim
EKEun Kyung Kim
Eun Kyung Kim
YKYoungmee Kwon
Youngmee Kwon
Background: Papillary breast lesions (PBLs) comprise diverse entities from benign and atypical lesions to malignant tumors. Although PBLs are characterized by a papillary growth pattern, it is challenging to achieve high diagnostic accuracy and reproducibility. Thus, we investigated the diagnostic reproducibility of PBLs in core needle biopsy (CNB) specimens with World Health Organization (WHO) classification.Methods: Diagnostic reproducibility was assessed using interobserver variability (kappa value, κ) and agreement rate in the pathologic diagnosis of 60 PBL cases on CNB among 20 breast pathologists affiliated with 20 medical institutions in Korea. This analysis was performed using hematoxylin and eosin (H&E) staining and immunohistochemical (IHC) staining for cytokeratin 5 (CK5) and p63. The pathologic diagnosis of PBLs was based on WHO classification, which was used to establish simple classifications (4-tier, 3-tier, and 2-tier). Results: On WHO classification, H&E staining exhibited ‘fair agreement’ (κ = 0.21) with a 47.0% agreement rate. Simple classifications presented improvement in interobserver variability and agreement rate. IHC staining increased the kappa value and agreement rate in all the classifications. Despite IHC staining, the encapsulated/solid papillary carcinoma (EPC/SPC) subgroup (κ = 0.16) exhibited lower agreement compared to the non-EPC/SPC subgroup (κ = 0.35) with WHO classification, which was similar to the results of any other classification systems. Conclusions: Although the use of IHC staining for CK5 and p63 increased the diagnostic agreement of PBLs in CNB specimens, WHO classification exhibited a higher discordance rate compared to any other classifications. Therefore, this result warrants further intensive consensus studies to improve the diagnostic reproducibility of PBLs with WHO classification.

9 October 2024 in Diagnostic Cytopathology
Verified
Journal Article
Open access
CWChang Gok Woo
Chang Gok Woo
SSSeung‐Myoung Son
Seung‐Myoung Son
HHHye‐Kyung Hwang
Hye‐Kyung Hwang
JBJung‐Sil Bae
Jung‐Sil Bae
OLOk‐Jun Lee
Ok‐Jun Lee
HLHo-Chang Lee
Ho-Chang Lee
Background: Cytology has long been a major screening method for cervical cancer prevention. Human papillomavirus (HPV) testing has recently been introduced for cervical cancer screening, and HPV tests become a major screening method in some countries. To seek the optimal strategy considering the cost‐effectiveness for cervical cancer screening, we compared the performance of primary LBC, primary HPV test, and LBC plus HPV co‐test in real practice.Methods: From March 2016 to June 2018, 3742 patients were included in this study. Liquid‐based cytology (LBC), HPV test, and histopathological assessment were performed in 3727, 1063, and 508 cases, respectively. The sensitivity, specificity, and cost–benefit effects of primary HPV, primary LBC, and co‐test algorithms were simulated for 317 cases with LBC, HPV, and histopathological results.Results: On the LBC, 13.0% of the cases were diagnosed with atypical squamous cells of undetermined significance or higher grade lesions. In the HPV test, high‐risk HPV was found in 43.5%, and 11.9% was positive for HPV type 16 or 18. Among the three simulated algorithms, the co‐test demonstrated the best sensitivity (97.5%) and the lowest specificity (50.3%). The primary LBC demonstrated the best specificity (53.5%) and a slightly better sensitivity, compare with the primary HPV (95.1% vs. 93.8%). Using the primary LBC algorithm, 82.0% can be determined without additional HPV test, whereas 50.1% could be determined without additional LBC using the primary HPV algorithm.Conclusions: The primary LBC algorithm for uterine cervical cancer (UCC) screening is comparable to the primary HPV algorithm and has the best cost–benefit effect among the three algorithms.